| Product Name | MF | CAS | Details |
|---|
| NRGN Human | Details |
| 6H,7H,8H,9H,11H-Pyrido[2,1-b]quinazolin-11-one | C12H12N2O | 2446-62-0 | Details |
| [(1R,2E,8S,10R,11S)-6-(Acetyloxymethyl)-11-hydroxy-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.03,7]tetradeca-2,6-dien-8-yl] (E)-2- methylbut-2-enoate | C22H28O8 | 83182-58-5 | Details |
| 1-Methyl-4-nitro-1H-pyrazol-3-ol | C4H5N3O3 | 1458593-78-6 | Details |
| Pyridine-3-yl-methanesulfonyl chloride hydrochloride | C6H7Cl2NO2S | 191105-35-8 | Details |
| C-Peptide 1 (rat) | C140H228N38O51 | 41475-27-8 | Details |
| 6-Fluoro-2H-chromene-3-carboxylic acid | C10H7FO3 | 452076-93-6 | Details |
| N-Ethyl-4-chloroaniline | C8H10ClN | 13519-75-0 | Details |
| Solvent Blue 4 | C33H33N3O | 6786-83-0 | Details |
| 4-Amino-5-chloro-2-methoxybenzamide | C8H9ClN2O2 | 24190-74-7 | Details |
| 4-Ethyl-1H-pyrrole-2-carboxylic acid | C7H9NO2 | 1354769-90-6 | Details |
| Complement C3 antibody | Details |
| {4H,5H,6H,7H-Pyrazolo[1,5-a]pyrazin-3-yl}methanol | C7H11N3O | 1221279-26-0 | Details |
| Sasanlimab | 2206792-50-7 | Details |
| Isoglabrone | C20H16O5 | 1115012-65-1 | Details |
| 1,2-Distearoyl-d70-sn-glycero-3-phosphocholine-1,1,2,2-d4 | C44H88NO8P | 326495-38-9 | Details |
| Methyl 5-bromo-2-nitrobenzoate | C8H6BrNO4 | 883554-93-6 | Details |
| 2-Isopropyl-6-methylpyrimidin-4-amine | C8H13N3 | 4595-70-4 | Details |
| 1-(2-Ethoxyethyl)-piperazine | C8H18N2O | 13484-38-3 | Details |
| 5-(2-Fluorophenyl)-5-methylimidazolidine-2,4-dione | C10H9FN2O2 | 7248-25-1 | Details |
| 7-Methyl-1H-indol-5-ol | C9H9NO | 53233-87-7 | Details |
| MLTK antibody | Details |
| TACI antibody | Details |
| 2,3-Dihydro-1-benzofuran-5-sulfonyl azide | C8H7N3O3S | 1152874-08-2 | Details |
| 5-({[2-(Dimethylamino)ethyl](methyl)amino}methyl)pyridin-2-amine | C11H20N4 | 1197332-20-9 | Details |
| tert-Butyl 6-chloro-1H,2H,3H-pyrrolo[2,3-b]pyridine-1-carboxylate | C12H15ClN2O2 | 679392-22-4 | Details |
| Anti VIP (Human, Porcine) Serum | Details |
| Rabbit anti Mouse Lambda Chain (biotin) | Details |
| 2-[(4-Formyl-1,3-dimethyl-1H-pyrazol-5-yl)sulfanyl]acetic acid | C8H10N2O3S | 1221725-60-5 | Details |
| Methyl 5-amino-3-chloro-2-fluorobenzoate | C8H7ClFNO2 | 1507502-79-5 | Details |
| 1-[(4-Amino-3-fluorophenyl)methyl]pyrrolidin-3-ol dihydrochloride | C11H16ClFN2O | 1803582-76-4 | Details |
| RNF126 antibody | Details |
| 3-(Chloromethyl)-1-(4-fluorophenyl)-1H,4H,5H,6H-cyclopenta[C]pyrazole | C13H12ClFN2 | 1221726-10-8 | Details |
| 3-Chloro-4-(2-methoxy-ethoxy)-phenylamine | C9H12ClNO2 | 879047-68-4 | Details |
| 4-Amino-2-bromopyridine-3-carbonitrile | C6H4BrN3 | 1806963-70-1 | Details |
| (2,2-Dimethylthiolan-3-yl)methanol | C7H14OS | 83413-95-0 | Details |
| YASESISGIPSR* – SIL Cetuximab signature peptide quantifier | Details |
| N-(2-Aminoethyl)-N-[5-(trifluoromethyl)-pyridin-2-yl]amine | C8H10F3N3 | 207557-34-4 | Details |
| Acamprosate calcium salt - Bio-X ? | C10H20CaN2O8S2 | 77337-73-6 | Details |
| 2-[(2,4-Dichlorobenzoyl)amino]acetic acid | C9H7Cl2NO3 | 7554-79-2 | Details |
| 7,8,3'-Trihydroxyflavone | C15H10O5 | 137502-84-2 | Details |
| 5-Fluoro-2,3-dihydro-1-benzofuran-3-carboxylic acid | C9H7FO3 | 93670-19-0 | Details |
| Goat anti Human IgE (epsilon chain) (FITC) | Details |
| 3-Chloro-4-(piperidin-1-yl)phenol hydrobromide | C11H15BrClNO | 1909312-54-4 | Details |
| Cholic acid monoclonal antibody | Details |
| H-TSDLIVLGLPWK-OH | Details |
| Measles Virus IgM Positive Human Plasma | Details |
| H-AEVIWTSSDHQVLSGK-OH | Details |
| 3,10-Dioxa-7-azaspiro[5.6]dodecane | 2260936-88-5 | Details |
| GD1b-Ganglioside ammonium | C84H148N4O40 | 19553-76-5 | Details |
| Ethyl 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-b-D-thioglucopyranoside | C22H25NO9S | 99409-32-2 | Details |
| Globotriose-APE-HSA | Details |
| Diethyl 2-(2,2,2-trifluoroacetyl)succinate | C10H13F3O5 | 94633-25-7 | Details |
| Trifluoroacetaldehyde methyl hemiacetal | C3H5F3O2 | 431-46-9 | Details |
| 5-Bromo-2-(1H-imidazol-2-yl)pyridine | C8H6BrN3 | 1211586-40-1 | Details |
| 4-Bromo-2-sulfanylbenzoic acid | C7H5BrO2S | 116209-30-4 | Details |
| Tripelennamine | C16H21N3 | 91-81-6 | Details |
| 5-Chloroquinazolin-2-amine | C8H6ClN3 | 190273-70-2 | Details |
| 2-Dechloroethylifosfamide | C5H12ClN2O2P | 53459-55-5 | Details |
| Potassium 2-fluoro-2-(4-methyl-1,3-thiazol-2-yl)acetate | C6H7FKNO2S | 1461715-74-1 | Details |
| N-(2,4-Difluorophenyl)-2-indol-3-yl-2-oxoethanamide | C16H10F2N2O2 | 946387-17-3 | Details |
| H-EEAPSLRPAPPPISGGGYR-OH | Details |
| D-Gln19-Tirzepatide | Details |
| N6-Benzoyl-5'-O-DMT-adenosine 3'-CE phosphoramidite | Details |
| tert-Butyl 5-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate | C14H19NO3 | 216064-48-1 | Details |
| Locustachykinin II | C50H76N14O12 | Details |
| Methyl 1-boc-3-hydroxyazetidine-3-carboxylate | C10H17NO5 | 1884303-05-2 | Details |
| 1-[(4-Hydroxyphenyl)methyl]cyclopropane-1-carboxylic acid | C11H12O3 | 1512778-52-7 | Details |
| DLK2 antibody | Details |
| tert-Butyl (2E)-3-[4-(benzyloxy)phenyl]prop-2-enoate | C20H22O3 | 691905-29-0 | Details |
| 3-[2-(Difluoromethoxy)phenyl]-1,2-oxazol-5-amine | C10H8F2N2O2 | 1021245-69-1 | Details |
| N,N'-Dibenzoyl-L-cystine | C20H20N2O6S2 | 25129-20-8 | Details |
| Benzeneacetic acid, 3,5-difluoro-hydroxy-, (S)- | C8H6F2O3 | 209982-91-2 | Details |
| Amyloid beta-Protein (25-35) amide trifluoroacetate salt | C45H82N14O13S | 147490-49-1 | Details |
| NHS-Biotin | C14H19N3O5S | 35013-72-0 | Details |
| 6-(Bromomethyl)-2,2-dimethyloxane | C8H15BrO | 1871726-65-6 | Details |
| 3-(Difluoromethyl)-4-methyl-4H-1,2,4-triazole | C4H5F2N3 | 1461706-95-5 | Details |
| 5-(Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole hyrochloride | C13H18BClN2O2 | 2377608-65-4 | Details |
| 2-(Piperidin-4-yl)benzonitrile | C12H14N2 | 304462-63-3 | Details |
| 2,5-Dichloro-1,4-benzoquinone | C6H2Cl2O2 | 615-93-0 | Details |
| Ehrlichia Canis gp36 Antigen, Recombinant | Details |
| Pulcherriminic acid | C12H20N2O4 | 957-86-8 | Details |
| 2-Debenzoyl paclitaxel 2-pentanoate | C45H55NO14 | 213767-22-7 | Details |
| 5-Methyl-2-oxo-1,3-oxazolidine-4-carboxylic acid | C5H7NO4 | 1195-19-3 | Details |
| 5-Methoxy-1,3-dimethyl-1H-pyrazole-4-carbonitrile | C7H9N3O | 1343203-74-6 | Details |
| Erk1/2 inhibitor 1 | C29H32ClN5O4 | 2095719-90-5 | Details |
| APP antibody (HRP) | Details |
| alpha Actinin 1 Blocking Peptide | Details |
| CHAC1 Blocking Peptide | Details |
| H-ISQAVHAAHAEINEA-OH | Details |
| Edivoxetine hydrochloride | C18H27ClFNO4 | 1194374-05-4 | Details |
| Methyl 2-(2-oxo-1,2,3,4-tetrahydroquinolin-1-yl)acetate | C12H13NO3 | 600167-15-5 | Details |
| 4-Chloro-2-[(2,2,2-trifluoroethyl)amino]benzoic acid | C9H7ClF3NO2 | 1341457-94-0 | Details |
| 5-(1-Phenyl-1H-pyrazol-4-yl)-1,2-oxazole-4-carboxylic acid | C13H9N3O3 | 1500627-24-6 | Details |
| NMDAR2A antibody | Details |
| 2-(6-Chloro-2-methyl-4-phenylquinolin-3-yl)acetic acid hydrochloride | C18H15Cl2NO2 | 1170172-16-3 | Details |
| [6-(Aminomethyl)piperidin-2-yl]methanol | C7H16N2O | 1461714-67-9 | Details |
| tert-Butyl (2R,4R)-4-hydroxypyrrolidine-2-carboxylate | C9H17NO3 | 1360617-83-9 | Details |
| 2-Chloro-5,6,7,8-tetrahydro-1,6-naphthyridine-3-carbonitrile | C9H8ClN3 | 1211515-10-4 | Details |
| 7-Hydroxy-4-chromone | C9H6O3 | 59887-89-7 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 | ||||